Antibody-associated diseases of the gray matter of the CNS. Diagnosis and treatment;Antikörperassoziierte Erkrankungen der grauen Substanz des ZNS: Diagnostik und Therapie

Nervenarzt

Volumn 82, Issue 8, 2011, Pages 986-993

  Bien, C G ^a  

^a EPILEPSY CENTER BETHEL   (Germany)

Author keywords

Antibody associated diseases; Central nervous system; Diagnosis; Gray matter; Treatment

Indexed keywords

AUTOANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; GRAY MATTER; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; ALGORITHMS; ANTIBODY SPECIFICITY; ANTIGENS, SURFACE; AUTOANTIBODIES; BRAIN; BRAIN DISEASES; CHILD; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DIAGNOSIS, DIFFERENTIAL; EPILEPSY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LIMBIC ENCEPHALITIS; MAGNETIC RESONANCE IMAGING; NEURONS; PROTEIN ARRAY ANALYSIS; PROTEINS; SYNDROME;

EID: 80755142819     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-011-3257-z     Document Type: Article

References (54)

1. Ances BM, Vitaliani R, Taylor RA et al (2005) Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain 128:1764-1777 (Pubitemid 41373648)
2. Bataller L, Galiano R, Garcia-Escrig M et al (2010) Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology 74:265-267
3. Bien CG, Bauer J (2011) Which pathomechanism damages the brain in antibody-associated CNS disease? (editorial). Neurology (im Druck)
4. Bien CG, Urbach H, Schramm J et al (2007) Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 69:1236-1244 (Pubitemid 47429024)
5. Boronat A, Sabater L, Saiz A et al (2011) GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 76:795-800
6. Brain L, Jellinek EH, Ball K (1966) Hashimoto's disease and encephalopathy. Lancet 2:512-514
7. Buckley C, Oger J, Clover L et al (2001) Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 50:73-78
8. Castillo P, Woodruff B, Caselli R et al (2006) Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 63:197-202 (Pubitemid 43261730)
9. Clerinx K, Breban T, Schrooten M et al (2011) Progressive encephalomyelitis with rigidity and myoclonus: resolution after thymectomy. Neurology 76:303-304
10. Dalakas MC, Fujii M, Li M et al (2001) High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 345:1870-1876 (Pubitemid 33716561)
11. Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091-1098
12. Dalmau J, Lancaster E, Martinez-Hernandez E et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63-74
13. Dalmau J, Rosenfeld MR (2008) Paraneoplastic syndromes of the CNS. Lancet Neurol 7:327-340 (Pubitemid 351380534)
14. Dalmau J, Tüzün E, Wu HY et al (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25-36 (Pubitemid 46214241)
15. Darnell RB, Posner JB (2005) A new cause of limbic encephalopathy. Brain 128:1745-1746 (Pubitemid 41373646)
16. Graus F, Boronat A, Xifro X et al (2010) The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 74:857-859
17. Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135-1140 (Pubitemid 39005770)
18. Graus F, Saiz A, Lai M et al (2008) Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 71:930-936
19. Gultekin SH, Rosenfeld MR, Voltz R et al (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123:1481-1494 (Pubitemid 30420947)
20. Haberlandt E, Bast T, Ebner A et al (2011) Limbic encephalitis in children and adolescents. Arch Dis Child 96:186-191
21. Honnorat J, Saiz A, Giometto B et al (2001) Cere-bellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58:225-230 (Pubitemid 32163159)
22. Hughes EG, Peng X, Gleichman AJ et al (2010) Cellular and synaptic mechanisms of ant i-NMDA receptor encephalitis. J Neurosci 30:5866-5875
23. Hutchinson M, Waters P, Mchugh J et al (2008) Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 71:1291-1292
24. Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and con-tactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133:2734-2748
25. Irani SR, Bera K, Waters P et al (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655-1667
26. Irani SR, Buckley C, Vincent A et al (2008) Im-munotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71:1647-1648
27. Irani SR, Michell AW, Lang B et al (2011) Faciobra-chial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69:892-900
28. Jarius S, Hoffmann LA, Stich O et al (2008) Relative frequency of VGKC and "classical" paraneoplastic antibodies in patients with limbic encephalitis. J Neurol 255:1100-1101
29. Lai M, Hughes EG, Peng X et al (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65:424-434
30. Lai M, Huijbers MG, Lancaster E et al (2010) Investigation of LGI1 astheantigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776-785
31. Lalic T, Pettingill P, Vincent A et al (2011) Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission. Epilepsia 52:121-131
32. Lancaster E, Huijbers MG, Bar V et al (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69:303-311
33. Lancaster E, Lai M, Peng X et al (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67-76
34. Leypoldt F, Blaes F, Rauer S et al (2011) Paraneoplastische Syndrome. In: Diener HC (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart (im Druck)
35. Liimatainen S, Peltola M, Sabater L et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760-767
36. Llado A, Mannucci P, Carpentier AF et al (2004) Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes. Neurology 63:1947-1949 (Pubitemid 39532399)
37. Majoie HJ, De BM, Renier W et al (2006) Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res 71:135-141 (Pubitemid 44419592)
38. Malter MP, Helmstaedter C, Urbach H et al (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470-478
39. Mas N, Saiz A, Leite MI et al (2011) Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (im Druck)
40. Mata S, Muscas GC, Naldi I et al (2008) Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 199:155-159
41. Mazzi G, Roia DD, Cruciatti B et al (2008) Plasma exchange for anti-GAD associated non paraneoplastic limbic encephalitis. Transfus Apher Sci 39:229-233
42. Mcknight K, Jiang Y, Hart Y et al (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730-1736
43. Meinck HM, Faber L, Morgenthaler N et al (2001) Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J Neurol Neurosurg Psychiatry 71:100-103
44. Meinck HM, Thompson PD (2002) Stiff man syndrome and related conditions. Mov Disord 17:853-866 (Pubitemid 36040990)
45. Mocellin R, Walterfang M, Velakoulis D (2007) Hashimoto's Encephalopathy: Epidemiology, Pathogenesis and Management. CNS Drugs 21:799-811 (Pubitemid 47443302)
46. Pittock SJ, Kryzer TJ, Lennon VA (2004) Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 56:715-719 (Pubitemid 39540753)
47. Saiz A, Blanco Y, Sabater L et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131(10):2553-2563
48. Shillito P, Molenaar PC, Vincent A et al (1995) Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 38:714-722
49. Thieben MJ, Lennon VA, Boeve BF et al (2004) Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62:1177-1182 (Pubitemid 38456513)
50. Tüzün E, Erdag E, Durmus H et al (2011) Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis. Neurol India 59:47-50
51. Turner MR, Irani SR, Leite IM et al (2011) Glycine & NMDA receptor antibodies in progressive encephalomyelitis with rigidity & myoclonus. Neurology (im Druck)
52. Vincent A, Bien CG, Irani SR et al (2011) Autoantibodies and diseases of the central nervous system: new developments and future challenges. Lancet Neurol (in press)
53. Vincent A, Buckley C, Schott JM et al (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsiveform of limbic encephalitis. Brain 127:701-712 (Pubitemid 38295483)
54. Prüss H, Dalmau J, Harms L et al (2010) Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 75:1735-1739